Anixa Biosciences, Inc. (ANIX)
3.60
0.00 (0.00%)
USD |
NASDAQ |
Aug 27, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences EPS Diluted (TTM) : -0.3032 for April 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| April 30, 2026 | -0.3032 |
| January 31, 2026 | -0.3149 |
| October 31, 2025 | -0.3366 |
| July 31, 2025 | -0.3446 |
| April 30, 2025 | -0.3773 |
| January 31, 2025 | -0.3891 |
| October 31, 2024 | -0.3937 |
| July 31, 2024 | -0.3906 |
| April 30, 2024 | -0.3695 |
| January 31, 2024 | -0.3451 |
| October 31, 2023 | -0.3167 |
| July 31, 2023 | -0.3432 |
| April 30, 2023 | -0.3523 |
| January 31, 2023 | -0.3958 |
| October 31, 2022 | -0.4478 |
| July 31, 2022 | -0.4684 |
| April 30, 2022 | -0.5205 |
| January 31, 2022 | -0.4867 |
| October 31, 2021 | -0.4474 |
| July 31, 2021 | -0.4055 |
| April 30, 2021 | -0.3738 |
| January 31, 2021 | -0.4149 |
| October 31, 2020 | -0.4523 |
| July 31, 2020 | -0.4633 |
| April 30, 2020 | -0.4592 |
| Date | Value |
|---|---|
| January 31, 2020 | -0.4636 |
| October 31, 2019 | -0.593 |
| July 31, 2019 | -0.7707 |
| April 30, 2019 | -0.9642 |
| January 31, 2019 | -0.915 |
| October 31, 2018 | -0.7704 |
| July 31, 2018 | -0.60 |
| April 30, 2018 | -0.42 |
| January 31, 2018 | -0.32 |
| October 31, 2017 | -0.62 |
| July 31, 2017 | -0.63 |
| April 30, 2017 | -0.64 |
| January 31, 2017 | -0.81 |
| October 31, 2016 | -0.58 |
| July 31, 2016 | -0.6081 |
| April 30, 2016 | -0.6581 |
| January 31, 2016 | -0.7581 |
| October 31, 2015 | -0.0781 |
| July 31, 2015 | -0.2888 |
| April 30, 2015 | -0.0628 |
| January 31, 2015 | -0.3128 |
| October 31, 2014 | -1.313 |
| July 31, 2014 | -1.304 |
| April 30, 2014 | -1.350 |
| January 31, 2014 | -1.100 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |
| Sangamo Therapeutics, Inc. | -0.383 |
| Sarepta Therapeutics, Inc. | -2.898 |
| Vicapsys Life Sciences, Inc. | -0.0223 |